ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01169584
Recruitment Status : Completed
First Posted : July 26, 2010
Last Update Posted : January 21, 2016
Sponsor:
Collaborator:
Solving Kids’ Cancer
Information provided by (Responsible Party):
SillaJen, Inc. ( Jennerex Biotherapeutics )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : November 2014